Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell C Dale

Showing results (231-240 of 353) with videos related to

Pageof 36
Sort By:
Clinical & Translational Immunology|April 22, 2026
cGAS inhibitor IMSB301 modifies interferon signalling in peripheral mononuclear cells of <i>SAMHD1</i> genetic interferonopathy <i>in vitro</i>Velda X Han, Jessica P Hayes, Lijun Sun, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 19, 2020
Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patientTania Cellucci, Heather Van Mater, Francesc Graus, et al.
Brain & Development|October 27, 2021
Autosomal dominant ADAR c.3019G>A (p.(G1007R)) variant is an important mimic of hereditary spastic paraplegia and cerebral palsyHannah F Jones, Marion Stoll, Gladys Ho, et al.
Epilepsy & Behavior Reports|July 28, 2022
Predictors of longitudinal seizure outcomes after epilepsy surgery in childhoodAmy Ka, Amir Taher, Stephanie D'Souza, et al.
Clinical & Translational Immunology|June 30, 2026
Early brain-penetrant immunotherapy reverses interferon signature and improves motor outcome in a case of ADAR1-related Aicardi-Goutières syndromeRussell C Dale, Jessica Hayes, Velda X Han, et al.
The Journal of Pediatrics|June 28, 2021
Respiratory Syncytial Virus-Associated Neurologic Complications in Children: A Systematic Review and Aggregated Case SeriesGemma L Saravanos, Catherine L King, Lucy Deng, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 30, 2019
Myoclonus-dystonia caused by GNB1 mutation responsive to deep brain stimulationHannah F Jones, Hugo Morales-Briceño, Katy Barwick, et al.
Brain : a Journal of Neurology|October 16, 2012
Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disordersRussell C Dale, Vera Merheb, Sekhar Pillai, et al.
Annals of Clinical and Translational Neurology|February 19, 2026
Ketogenic Diet as an Epigenetic Therapy in SETD1B-Related EpilepsyErica Tsang, Brian S Gloss, Jessica P Hayes, et al.
Journal of Child Neurology|April 7, 2026
Implementation of Paediatric Deep Brain Stimulation: Experience from an Australian Tertiary CentreJamie M Barnacoat, Wafa Bani Uraba, Dianah Hadi, et al.
Pageof 36

Showing results (231-240 of 353) with videos related to

Sort By:
Pageof 36
Clinical & Translational Immunology|April 22, 2026
cGAS inhibitor IMSB301 modifies interferon signalling in peripheral mononuclear cells of <i>SAMHD1</i> genetic interferonopathy <i>in vitro</i>Velda X Han, Jessica P Hayes, Lijun Sun, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 19, 2020
Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patientTania Cellucci, Heather Van Mater, Francesc Graus, et al.
Brain & Development|October 27, 2021
Autosomal dominant ADAR c.3019G>A (p.(G1007R)) variant is an important mimic of hereditary spastic paraplegia and cerebral palsyHannah F Jones, Marion Stoll, Gladys Ho, et al.
Epilepsy & Behavior Reports|July 28, 2022
Predictors of longitudinal seizure outcomes after epilepsy surgery in childhoodAmy Ka, Amir Taher, Stephanie D'Souza, et al.
Clinical & Translational Immunology|June 30, 2026
Early brain-penetrant immunotherapy reverses interferon signature and improves motor outcome in a case of ADAR1-related Aicardi-Goutières syndromeRussell C Dale, Jessica Hayes, Velda X Han, et al.
The Journal of Pediatrics|June 28, 2021
Respiratory Syncytial Virus-Associated Neurologic Complications in Children: A Systematic Review and Aggregated Case SeriesGemma L Saravanos, Catherine L King, Lucy Deng, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 30, 2019
Myoclonus-dystonia caused by GNB1 mutation responsive to deep brain stimulationHannah F Jones, Hugo Morales-Briceño, Katy Barwick, et al.
Brain : a Journal of Neurology|October 16, 2012
Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disordersRussell C Dale, Vera Merheb, Sekhar Pillai, et al.
Annals of Clinical and Translational Neurology|February 19, 2026
Ketogenic Diet as an Epigenetic Therapy in SETD1B-Related EpilepsyErica Tsang, Brian S Gloss, Jessica P Hayes, et al.
Journal of Child Neurology|April 7, 2026
Implementation of Paediatric Deep Brain Stimulation: Experience from an Australian Tertiary CentreJamie M Barnacoat, Wafa Bani Uraba, Dianah Hadi, et al.
Pageof 36